{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T16:57:46Z","timestamp":1781629066818,"version":"3.54.5"},"reference-count":53,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,1,5]],"date-time":"2026-01-05T00:00:00Z","timestamp":1767571200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,2,3]],"date-time":"2026-02-03T00:00:00Z","timestamp":1770076800000},"content-version":"vor","delay-in-days":29,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Non-alcoholic fatty liver disease (NAFLD) is a chronic hepatic illness linked with metabolic dysfunction that is distinguished by aberrant lipid accumulation in hepatocytes. Emerging evidence indicates an elevated risk of atherosclerosis (AS) in NAFLD patients, but the fundamental biological processes are not well comprehended. The present research aims to uncover co-expressed oxidative stress-related hub genes as well as potential mechanisms shared between NAFLD and AS through bioinformatics and machine learning approaches. Gene expression profiles of NAFLD (GSE89632, Allard JP et al.) and AS (GSE100927, Steenman M et al.) were retrieved from the Gene Expression Omnibus (GEO) database. Oxidative stress-related genes were extracted from the GeneCards database. Differential expression analysis identified shared differentially expressed genes between both diseases. Functional enrichment analysis elucidated associated biological processes. Machine learning approaches were employed to screen for oxidative stress-related hub genes. Differential expression analysis revealed 20 co-expressed oxidative stress-related genes (8 upregulated, 12 downregulated) in NAFLD and AS. Functional enrichment analysis revealed that these genes are predominantly associated with biological processes, including the\n                    <jats:italic>MAPK<\/jats:italic>\n                    as well as the\n                    <jats:italic>FoxO<\/jats:italic>\n                    signaling pathway. Machine learning methods identified\n                    <jats:italic>ADM<\/jats:italic>\n                    and\n                    <jats:italic>IL2RB<\/jats:italic>\n                    as co-expressed oxidative stress-related hub genes with significant diagnostic potential, with Area Under Curve (AUC) values of 0.787 and 0.887 for AS, and 0.979 and 0.931 for NAFLD. The nomogram model utilizing the two hub genes demonstrated excellent predictive accuracy, with AUC values exceeding 0.9 in both diseases. The present study investigated potential important oxidative stress-related molecules as well as pathogenic processes among NAFLD and AS, offering fresh insights for finding potential biomarkers and treating both diseases in future studies.\n                  <\/jats:p>","DOI":"10.1038\/s41598-025-34958-5","type":"journal-article","created":{"date-parts":[[2026,1,5]],"date-time":"2026-01-05T16:19:10Z","timestamp":1767629950000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Identification of shared oxidative stress related hub genes in NAFLD and atherosclerosis using bioinformatics and machine learning"],"prefix":"10.1038","volume":"16","author":[{"given":"Gong","family":"Qing","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bo","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huizhen","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,1,5]]},"reference":[{"issue":"3","key":"34958_CR1","doi-asserted-by":"publisher","first-page":"842","DOI":"10.1016\/j.jhep.2023.04.036","volume":"79","author":"VWS Wong","year":"2023","unstructured":"Wong, V. W. S., Ekstedt, M., Wong, G. L. H. & Hagstr\u00f6m, H. Changing epidemiology, global trends and implications for outcomes of NAFLD. J. Hepatol. 79 (3), 842\u2013852 (2023).","journal-title":"J. Hepatol."},{"issue":"8","key":"34958_CR2","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1038\/s41574-022-00675-6","volume":"18","author":"E Barreby","year":"2022","unstructured":"Barreby, E., Chen, P. & Aouadi, M. Macrophage functional diversity in NAFLD - more than inflammation. Nat. Rev. Endocrinol. 18 (8), 461\u2013472 (2022).","journal-title":"Nat. Rev. Endocrinol."},{"issue":"1","key":"34958_CR3","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1038\/s41575-021-00523-4","volume":"19","author":"JV Lazarus","year":"2022","unstructured":"Lazarus, J. V. et al. Advancing the global public health agenda for NAFLD: a consensus statement. Nat. Reviews Gastroenterol. Hepatol. 19 (1), 60\u201378 (2022).","journal-title":"Nat. Reviews Gastroenterol. Hepatol."},{"issue":"Suppl","key":"34958_CR4","doi-asserted-by":"publisher","first-page":"S32","DOI":"10.3350\/cmh.2022.0365","volume":"29","author":"ML Teng","year":"2023","unstructured":"Teng, M. L. et al. Global incidence and prevalence of nonalcoholic fatty liver disease. Clin. Mol. Hepatol. 29 (Suppl), S32\u2013S42 (2023).","journal-title":"Clin. Mol. Hepatol."},{"key":"34958_CR5","doi-asserted-by":"crossref","unstructured":"Han, S. K., Baik, S. K. & Kim, M. Y. Non-alcoholic fatty liver disease: definition and subtypes. Clin Mol. Hepatol. 29 (Suppl), S5\u2013S16 (2023).","DOI":"10.3350\/cmh.2022.0424"},{"key":"34958_CR6","doi-asserted-by":"publisher","first-page":"101092","DOI":"10.1016\/j.molmet.2020.101092","volume":"42","author":"A Deprince","year":"2020","unstructured":"Deprince, A., Haas, J. T. & Staels, B. Dysregulated lipid metabolism links NAFLD to cardiovascular disease. Mol. Metab. 42, 101092 (2020).","journal-title":"Mol. Metab."},{"issue":"10","key":"34958_CR7","doi-asserted-by":"publisher","first-page":"1325","DOI":"10.4254\/wjh.v7.i10.1325","volume":"7","author":"L Polimeni","year":"2015","unstructured":"Polimeni, L. et al. Oxidative stress: new insights on the association of non-alcoholic fatty liver disease and atherosclerosis. World J. Hepatol. 7 (10), 1325\u20131336 (2015).","journal-title":"World J. Hepatol."},{"key":"34958_CR8","doi-asserted-by":"crossref","unstructured":"Infante-Men\u00e9ndez, J., Gonz\u00e1lez-L\u00f3pez, P., Huertas-L\u00e1rez, R., G\u00f3mez-Hern\u00e1ndez, A. & Escribano, \u00d3. Oxidative stress modulation by NcRNAs and their emerging role as therapeutic targets in atherosclerosis and Non-Alcoholic fatty liver disease. Antioxidants (Basel). 12 (2), 262 (2023).","DOI":"10.3390\/antiox12020262"},{"key":"34958_CR9","doi-asserted-by":"publisher","first-page":"1050984","DOI":"10.3389\/fimmu.2022.1050984","volume":"13","author":"W Sheng","year":"2022","unstructured":"Sheng, W., Ji, G. & Zhang, L. Role of macrophage scavenger receptor MSR1 in the progression of non-alcoholic steatohepatitis. Front. Immunol. 13, 1050984 (2022).","journal-title":"Front. Immunol."},{"key":"34958_CR10","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1016\/j.freeradbiomed.2020.12.450","volume":"164","author":"W Yu","year":"2021","unstructured":"Yu, W. et al. Endothelial Nox4 dysfunction aggravates atherosclerosis by inducing Endoplasmic reticulum stress and soluble epoxide hydrolase. Free Radic Biol. Med. 164, 44\u201357 (2021).","journal-title":"Free Radic Biol. Med."},{"key":"34958_CR11","doi-asserted-by":"crossref","unstructured":"Greatorex, S. et al. Mitochondria- and NOX4-dependent antioxidant defense mitigates progression to nonalcoholic steatohepatitis in obesity. J Clin. Invest. 134 (3), e162533 (2023).","DOI":"10.1172\/JCI162533"},{"issue":"6","key":"34958_CR12","doi-asserted-by":"publisher","first-page":"1129","DOI":"10.1007\/s10557-020-07018-5","volume":"35","author":"W Jiang","year":"2021","unstructured":"Jiang, W. et al. Idebenone protects against atherosclerosis in Apolipoprotein E-Deficient mice via activation of the SIRT3-SOD2-mtROS pathway. Cardiovasc. Drugs Ther. 35 (6), 1129\u20131145 (2021).","journal-title":"Cardiovasc. Drugs Ther."},{"issue":"7","key":"34958_CR13","doi-asserted-by":"publisher","first-page":"e47","DOI":"10.1093\/nar\/gkv007","volume":"43","author":"ME Ritchie","year":"2015","unstructured":"Ritchie, M. E. et al. Smyth GK: Limma powers differential expression analyses for RNA-sequencing and microarray studies. Nucleic Acids Res. 43 (7), e47 (2015).","journal-title":"Nucleic Acids Res."},{"issue":"15","key":"34958_CR14","first-page":"3844","volume":"38","author":"EK Gustavsson","year":"2022","unstructured":"Gustavsson, E. K., Zhang, D., Reynolds, R. H., Garcia-Ruiz, S. & Ryten, M. Ggtranscript: an R package for the visualization and interpretation of transcript isoforms using ggplot2. Bioinf. (Oxford England). 38 (15), 3844\u20133846 (2022).","journal-title":"Bioinf. (Oxford England)"},{"key":"34958_CR15","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1186\/1471-2105-12-35","volume":"12","author":"H Chen","year":"2011","unstructured":"Chen, H. & Boutros, P. C. VennDiagram: a package for the generation of highly-customizable Venn and Euler diagrams in R. BMC Bioinform. 12, 35 (2011).","journal-title":"BMC Bioinform."},{"issue":"18","key":"34958_CR16","first-page":"2847","volume":"32","author":"Z Gu","year":"2016","unstructured":"Gu, Z., Eils, R. & Schlesner, M. Complex heatmaps reveal patterns and correlations in multidimensional genomic data. Bioinf. (Oxford England). 32 (18), 2847\u20132849 (2016).","journal-title":"Bioinf. (Oxford England)"},{"issue":"5","key":"34958_CR17","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1089\/omi.2011.0118","volume":"16","author":"G Yu","year":"2012","unstructured":"Yu, G., Wang, L-G., Han, Y. & He, Q-Y. ClusterProfiler: an R package for comparing biological themes among gene clusters. OMICS 16 (5), 284\u2013287 (2012).","journal-title":"OMICS"},{"issue":"D1","key":"34958_CR18","doi-asserted-by":"publisher","first-page":"D457","DOI":"10.1093\/nar\/gkv1070","volume":"44","author":"M Kanehisa","year":"2016","unstructured":"Kanehisa, M., Sato, Y., Kawashima, M., Furumichi, M. & Tanabe, M. KEGG as a reference resource for gene and protein annotation. Nucleic Acids Res. 44 (D1), D457\u2013D462 (2016).","journal-title":"Nucleic Acids Res."},{"issue":"1","key":"34958_CR19","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1093\/nar\/28.1.27","volume":"28","author":"M Kanehisa","year":"2000","unstructured":"Kanehisa, M. & Goto, S. KEGG: Kyoto encyclopedia of genes and genomes. Nucleic Acids Res. 28 (1), 27\u201330 (2000).","journal-title":"Nucleic Acids Res."},{"issue":"11","key":"34958_CR20","doi-asserted-by":"publisher","first-page":"1947","DOI":"10.1002\/pro.3715","volume":"28","author":"M Kanehisa","year":"2019","unstructured":"Kanehisa, M. Toward Understanding the origin and evolution of cellular organisms. Protein Sci. 28 (11), 1947\u20131951 (2019).","journal-title":"Protein Sci."},{"issue":"D1","key":"34958_CR21","doi-asserted-by":"publisher","first-page":"D672","DOI":"10.1093\/nar\/gkae909","volume":"53","author":"M Kanehisa","year":"2025","unstructured":"Kanehisa, M., Furumichi, M., Sato, Y., Matsuura, Y. & Ishiguro-Watanabe, M. KEGG: biological systems database as a model of the real world. Nucleic Acids Res. 53 (D1), D672\u2013D677 (2025).","journal-title":"Nucleic Acids Res."},{"issue":"1","key":"34958_CR22","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1186\/s13148-019-0730-1","volume":"11","author":"S Engebretsen","year":"2019","unstructured":"Engebretsen, S. & Bohlin, J. Statistical predictions with Glmnet. Clin. Epigenetics. 11 (1), 123 (2019).","journal-title":"Clin. Epigenetics"},{"issue":"7","key":"34958_CR23","first-page":"951","volume":"33","author":"M Cinelli","year":"2017","unstructured":"Cinelli, M. et al. Feature selection using a one dimensional na\u00efve bayes\u2019 classifier increases the accuracy of support vector machine classification of CDR3 repertoires. Bioinf. (Oxford England). 33 (7), 951\u2013955 (2017).","journal-title":"Bioinf. (Oxford England)"},{"key":"34958_CR24","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1186\/1471-2105-14-7","volume":"14","author":"S H\u00e4nzelmann","year":"2013","unstructured":"H\u00e4nzelmann, S., Castelo, R. & Guinney, J. GSVA: gene set variation analysis for microarray and RNA-seq data. BMC Bioinform. 14, 7 (2013).","journal-title":"BMC Bioinform."},{"issue":"4","key":"34958_CR25","doi-asserted-by":"publisher","first-page":"782","DOI":"10.1016\/j.immuni.2013.10.003","volume":"39","author":"G Bindea","year":"2013","unstructured":"Bindea, G. et al. Spatiotemporal dynamics of intratumoral immune cells reveal the immune landscape in human cancer. Immunity 39 (4), 782\u2013795 (2013).","journal-title":"Immunity"},{"issue":"1","key":"34958_CR26","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1038\/s41420-024-02168-z","volume":"10","author":"H-L Xu","year":"2024","unstructured":"Xu, H-L. et al. Targeting cell death in NAFLD: mechanisms and targeted therapies. Cell. Death Discov. 10 (1), 399 (2024).","journal-title":"Cell. Death Discov"},{"issue":"8","key":"34958_CR27","doi-asserted-by":"publisher","first-page":"1856","DOI":"10.1111\/liv.15967","volume":"44","author":"Y Duan","year":"2024","unstructured":"Duan, Y. et al. Crosstalk in extrahepatic and hepatic system in NAFLD\/NASH. Liver Int. 44 (8), 1856\u20131871 (2024).","journal-title":"Liver Int."},{"key":"34958_CR28","doi-asserted-by":"crossref","unstructured":"Jebari-Benslaiman, S. et al. Pathophysiology of atherosclerosis. International J. Mol. Sciences. 23 (6), 3346 (2022).","DOI":"10.3390\/ijms23063346"},{"issue":"4","key":"34958_CR29","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1055\/a-1930-6658","volume":"42","author":"DQ Huang","year":"2022","unstructured":"Huang, D. Q. et al. Shared mechanisms between cardiovascular disease and NAFLD. Semin Liver Dis. 42 (4), 455\u2013464 (2022).","journal-title":"Semin Liver Dis."},{"key":"34958_CR30","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1016\/j.yjmcc.2021.10.007","volume":"163","author":"W Li","year":"2022","unstructured":"Li, W. et al. NAFLD as a continuous driver in the whole spectrum of vascular disease. J. Mol. Cell. Cardiol. 163, 118\u2013132 (2022).","journal-title":"J. Mol. Cell. Cardiol."},{"issue":"3","key":"34958_CR31","doi-asserted-by":"publisher","first-page":"188736","DOI":"10.1016\/j.bbcan.2022.188736","volume":"1877","author":"H-B Park","year":"2022","unstructured":"Park, H-B. & Baek, K-H. E3 ligases and deubiquitinating enzymes regulating the MAPK signaling pathway in cancers. Biochim. Biophys. Acta Rev. Cancer. 1877 (3), 188736 (2022).","journal-title":"Biochim. Biophys. Acta Rev. Cancer"},{"issue":"1","key":"34958_CR32","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1038\/s41392-022-01299-y","volume":"8","author":"Z Fang","year":"2023","unstructured":"Fang, Z. et al. Short-term Tamoxifen administration improves hepatic steatosis and glucose intolerance through JNK\/MAPK in mice. Signal. Transduct. Target. Therapy. 8 (1), 94 (2023).","journal-title":"Signal. Transduct. Target. Therapy"},{"issue":"1","key":"34958_CR33","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1016\/j.jhep.2019.03.014","volume":"71","author":"X Zhang","year":"2019","unstructured":"Zhang, X. et al. Macrophage p38\u03b1 promotes nutritional steatohepatitis through M1 polarization. J. Hepatol. 71 (1), 163\u2013174 (2019).","journal-title":"J. Hepatol."},{"key":"34958_CR34","doi-asserted-by":"crossref","unstructured":"Chu, T. et al. Kaempferol regulating macrophage foaming and atherosclerosis through Piezo1-mediated MAPK\/NF-\u03baB and Nrf2\/HO-1 signaling pathway. J Adv. Res. 75, 635\u2013650 (2024).","DOI":"10.1016\/j.jare.2024.11.016"},{"key":"34958_CR35","doi-asserted-by":"crossref","unstructured":"Chen, C-C. et al. Corylin inhibits vascular cell Inflammation, proliferation and migration and reduces atherosclerosis in ApoE-Deficient mice. Antioxidants (Basel). 9 (4),  275 (2020).","DOI":"10.3390\/antiox9040275"},{"issue":"12","key":"34958_CR36","doi-asserted-by":"publisher","first-page":"1070","DOI":"10.1016\/j.tips.2022.09.010","volume":"43","author":"A Orea-Soufi","year":"2022","unstructured":"Orea-Soufi, A. et al. FOXO transcription factors as therapeutic targets in human diseases. Trends Pharmacol. Sci. 43 (12), 1070\u20131084 (2022).","journal-title":"Trends Pharmacol. Sci."},{"issue":"1","key":"34958_CR37","doi-asserted-by":"publisher","first-page":"e0243938","DOI":"10.1371\/journal.pone.0243938","volume":"16","author":"N Zhao","year":"2021","unstructured":"Zhao, N. et al. Palmitate induces fat accumulation via repressing FoxO1-mediated ATGL-dependent lipolysis in HepG2 hepatocytes. PloS One. 16 (1), e0243938 (2021).","journal-title":"PloS One"},{"issue":"5","key":"34958_CR38","first-page":"1671","volume":"46","author":"J Liu","year":"2020","unstructured":"Liu, J., Yi, X., Tao, Y., Wang, Y. & Xu, Z. Insulin\u2013receptor substrate 1 protects against injury in endothelial cell models of ox\u2013LDL\u2013induced atherosclerosis by inhibiting ER stress\/oxidative stress\u2013mediated apoptosis and activating the Akt\/FoxO1 signaling pathway. Int. J. Mol. Med. 46 (5), 1671\u20131682 (2020).","journal-title":"Int. J. Mol. Med."},{"issue":"11","key":"34958_CR39","doi-asserted-by":"publisher","first-page":"e23452","DOI":"10.1002\/jbt.23452","volume":"37","author":"J Yuan","year":"2023","unstructured":"Yuan, J., Wang, Y., Wang, D., Yan, H. & Wang, N. Loxenatide attenuates ROS-mediated vascular endothelial progenitor cell damage and mitochondrial dysfunction via SIRT3\/Foxo3 signaling pathway. J. Biochem. Mol. Toxicol. 37 (11), e23452 (2023).","journal-title":"J. Biochem. Mol. Toxicol."},{"issue":"1","key":"34958_CR40","doi-asserted-by":"publisher","first-page":"2297","DOI":"10.1038\/s41467-025-57540-z","volume":"16","author":"O El Bounkari","year":"2025","unstructured":"El Bounkari, O. et al. An atypical atherogenic chemokine that promotes advanced atherosclerosis and hepatic lipogenesis. Nat. Commun. 16 (1), 2297 (2025).","journal-title":"Nat. Commun."},{"issue":"2","key":"34958_CR41","doi-asserted-by":"publisher","first-page":"552","DOI":"10.1016\/j.jhep.2023.03.038","volume":"79","author":"F Tacke","year":"2023","unstructured":"Tacke, F., Puengel, T., Loomba, R. & Friedman, S. L. An integrated view of anti-inflammatory and antifibrotic targets for the treatment of NASH. J. Hepatol. 79 (2), 552\u2013566 (2023).","journal-title":"J. Hepatol."},{"issue":"29","key":"34958_CR42","doi-asserted-by":"publisher","first-page":"2672","DOI":"10.1093\/eurheartj\/ehad304","volume":"44","author":"C Weber","year":"2023","unstructured":"Weber, C., Habenicht, A. J. R. & von Hundelshausen, P. Novel mechanisms and therapeutic targets in atherosclerosis: inflammation and beyond. Eur. Heart J. 44 (29), 2672\u20132681 (2023).","journal-title":"Eur. Heart J."},{"key":"34958_CR43","doi-asserted-by":"publisher","first-page":"170347","DOI":"10.1016\/j.peptides.2020.170347","volume":"131","author":"J-P Fischer","year":"2020","unstructured":"Fischer, J-P., Els-Heindl, S. & Beck-Sickinger, A. G. Adrenomedullin - Current perspective on a peptide hormone with significant therapeutic potential. Peptides 131, 170347 (2020).","journal-title":"Peptides"},{"issue":"5","key":"34958_CR44","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1007\/s00592-021-01840-5","volume":"59","author":"H-B Dai","year":"2022","unstructured":"Dai, H-B. et al. Adrenomedullin ameliorates palmitic acid-induced insulin resistance through PI3K\/Akt pathway in adipocytes. Acta Diabetol. 59 (5), 661\u2013673 (2022).","journal-title":"Acta Diabetol."},{"key":"34958_CR45","doi-asserted-by":"crossref","unstructured":"Wong, H. K., Cheung, T. T. & Cheung, B. M. Y. Adrenomedullin and cardiovascular diseases. JRSM Cardiovasc. Dis. 1 (5), cvd.2012.012003 (2012).","DOI":"10.1258\/cvd.2012.012003"},{"issue":"6","key":"34958_CR46","doi-asserted-by":"publisher","first-page":"1231","DOI":"10.1084\/jem.20190546","volume":"216","author":"TM Campbell","year":"2019","unstructured":"Campbell, T. M. & Bryceson, Y. T. IL2RB maintains immune harmony. J. Exp. Med. 216 (6), 1231\u20131233 (2019).","journal-title":"J. Exp. Med."},{"key":"34958_CR47","doi-asserted-by":"publisher","first-page":"110288","DOI":"10.1016\/j.clim.2024.110288","volume":"266","author":"C Sommer","year":"2024","unstructured":"Sommer, C. et al. Bridging therapy-induced phenotypes and genetic immune dysregulation to study interleukin-2-induced immunotoxicology. Clin. Immunol. 266, 110288 (2024).","journal-title":"Clin. Immunol."},{"issue":"4","key":"34958_CR48","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1038\/s41569-021-00629-x","volume":"19","author":"W Chen","year":"2021","unstructured":"Chen, W. et al. Macrophage-targeted nanomedicine for the diagnosis and treatment of atherosclerosis. Nat. Rev. Cardiol. 19 (4), 228\u2013249 (2021).","journal-title":"Nat. Rev. Cardiol."},{"issue":"11","key":"34958_CR49","doi-asserted-by":"publisher","first-page":"1015","DOI":"10.1038\/s44161-023-00354-3","volume":"2","author":"MT Patterson","year":"2023","unstructured":"Patterson, M. T. et al. Trem2 promotes foamy macrophage lipid uptake and survival in atherosclerosis. Nat. Cardiovasc. Res. 2 (11), 1015\u20131031 (2023).","journal-title":"Nat. Cardiovasc. Res."},{"issue":"7","key":"34958_CR50","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1038\/s41569-020-0352-5","volume":"17","author":"R Saigusa","year":"2020","unstructured":"Saigusa, R., Winkels, H. & Ley, K. T cell subsets and functions in atherosclerosis. Nat. Rev. Cardiol. 17 (7), 387\u2013401 (2020).","journal-title":"Nat. Rev. Cardiol."},{"issue":"19","key":"34958_CR51","doi-asserted-by":"publisher","first-page":"1391","DOI":"10.1161\/CIRCULATIONAHA.124.072384","volume":"151","author":"CA Bonfiglio","year":"2025","unstructured":"Bonfiglio, C. A. et al. Ezh2 shapes T cell plasticity to drive atherosclerosis. Circulation 151 (19), 1391\u20131408 (2025).","journal-title":"Circulation"},{"issue":"2","key":"34958_CR52","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1016\/j.jhep.2023.04.037","volume":"79","author":"E Kotsiliti","year":"2023","unstructured":"Kotsiliti, E. et al. Intestinal B cells license metabolic T-cell activation in NASH microbiota\/antigen-independently and contribute to fibrosis by IgA-FcR signalling. J. Hepatol. 79 (2), 296\u2013313 (2023).","journal-title":"J. Hepatol."},{"issue":"10","key":"34958_CR53","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1038\/s41575-023-00807-x","volume":"20","author":"L Hammerich","year":"2023","unstructured":"Hammerich, L. & Tacke, F. Hepatic inflammatory responses in liver fibrosis. Nat. Reviews Gastroenterol. Hepatol. 20 (10), 633\u2013646 (2023).","journal-title":"Nat. Reviews Gastroenterol. Hepatol."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-34958-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-34958-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-34958-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T16:07:26Z","timestamp":1781626046000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-34958-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,5]]},"references-count":53,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["34958"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-34958-5","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,5]]},"assertion":[{"value":"26 April 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 December 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"4644"}}